Blood inflammation test study in sudden brain oxygen loss
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial looks at blood “inflammation-related” biomarkers to understand what happens early after certain sudden brain events. It may help doctors predict outcomes and tailor treatment for people like those with stroke types that sometimes need a clot-removal procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re being admitted to the hospital very soon after sudden brain symptoms (within 36 hours for stroke types, within 7 days for a TIA).
- Your symptoms match specific diagnoses: eligible stroke types (ischemic stroke needing clot removal, subarachnoid bleeding, or a brain bleed in the tissue) or a suspected TIA based on interview and ABCD2 score.
- If you’re in the TIA group, you must be evaluated before the first brain scan and have an ABCD2 score of 2 or higher.
- You can give informed consent (or have legal ability to participate).
- You must have social security coverage (be a member or beneficiary).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain proteins in the blood change after a procedure to remove a large blockage in a brain artery. The goal is to better understand recovery after stroke treatment.
This study is testing whether certain substances in your blood can help doctors better detect and understand problems with blood flow in the brain. Researchers hope these new 'biomarkers' could lead to faster and more accurate diagnosis of conditions like stroke and mini-stroke.
This trial looks at how blood flow and brain activity change in the first days after a stroke caused by a large blockage in the front part of the brain. It tests if certain patterns can help predict recovery after a procedure to remove the clot.
This study looks for biological and imaging markers that may predict heart/vascular outcomes after an ischemic stroke. You may join if you are eligible for standard stroke treatment and can complete planned follow-up and MRI scans.
This study looks at brain swelling (“cerebral edema”) after a spontaneous brain bleed and how it relates to outcomes. It mainly involves people who can have early care and MRI scans, to better understand what affects recovery.
This study looks at how blood clots and inflammation interact after a stroke or bleeding in the brain to find new ways to treat these emergencies. If you join, researchers will study your blood to understand these processes, which may lead to better future treatments.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.